Firms
Theme

AEHR

Aehr Test Systems · NASDAQ

News

2 latest

Zacks Investment Research

Implied Volatility Surging for Aehr Stock Options

Aehr Test Systems (AEHR) is drawing attention from options traders due to high implied volatility in its Jan. 15, 2027 $2.50 Put options, suggesting market expectations for significant price movement. The company holds a Zacks Rank #3 (Hold) rating in the Electronics - Measuring Instruments industry, with analyst consensus estimates for the current quarter recently increased from 21 cents to 23 cents per share.

Zacks Investment Research

AEHR vs. CAMT: Which Semiconductor Equipment Stock Is the Better Bet?

Aehr Test Systems and Camtek are both positioned to benefit from AI and advanced packaging demand in semiconductors, but with different growth profiles. AEHR is entering a sharper growth phase with expected fiscal 2027 revenues of $130-$150 million (160%-200% growth) backed by a record $100.6 million backlog in AI-related burn-in solutions.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $AEHR · 0 threads

Sign in to post on $AEHR

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev